跳至主要内容
临床试验/CTRI/2016/02/006676
CTRI/2016/02/006676已完成未知

An open label study to evaluate the efficacy of Macumax capsules in adult male or female patients suffering from dry type Age related macular disorder.

Sami Labs Limited0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Patients of either sex, > 50 years of age.
  • 2 Patients having signs and symptoms of AMD (Dry type).
  • 3 Willing to come for regular follow up visits.
  • 4 Able to give written informed consent.

排除标准

  • 1 Known history of hypersensitivity to herbal extracts or dietary supplements.
  • 2 Patients having other ocular pathologies like glaucoma, high myopia, mature cataract, pan retinal degenerations etc. were excluded.
  • 3 Patients having systemic diseases like hyper cholesterolemia, renal disorder, liver disorder and other debilitating diseases.
  • 4 Pregnant women, lactating women and women of child bearing potential not following adequate contraceptive measure, women who were found positive for urine pregnancy test.
  • 5 On going treatment with herbal or allopathic ocular drugs.
  • 6 History of having received any investigational drug or participated in any other clinical trial which ended in preceding month or currently on going.

研究者

发起方
Sami Labs Limited

相似试验